Ares Genetics services and solutions

ARESdb is a database of AMR biomarkers comprehensively covering resistance genes and mutations. Unlike other databases, ARESdb informs on the diagnostic performance of AMR markers and enables the AI-powered prediction of AMR based on genome data.

To enable labs globally, Ares develops AREScloud, a user-friendly bioinformatics and reporting hub powered by ARESdb.

  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

  • Bacteria
  • Fungi
  • Viruses
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Marketed product
  • Research
  • Development
  • Validation
  • Market entry

  • Company
  • Academia
  • Institute
  • NGO
  • Government

  • License
  • Co-develop
  • Sell
  • Outsource
  • Joint Venture

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND

Infectious disease area:
  • UTI
  • RTI
  • SSI
  • STI
  • BSI
  • GII
  • SSTI
  • CNSI
  • IAI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania

IVD development partnership exploring the proprietary and IP protected ARESdb data asset for the development of NGS or high multiplex molecular diagnostic solutions.

Ares Genetics addresses the global challenge of antimicrobial resistance through innovative genome technologies and AI-powered bioinformatics.

Ares Genetics Solutions include isolate sequencing services (ARESiss), the culture-free universal pathogenome assay (ARESupa) comprehensively screening for pathogen and AMR markers, ARESdb and AREScloud, as well as tailored bioinformatics services.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!